Commentary

por Gozzetti, Alessandro
Publicado 2013

Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma

por GOZZETTI, ALESSANDRO, BOCCHIA, MONICA
Publicado 2023

Steps towards a Multiple Myeloma Cure?

por Gozzetti, Alessandro, Bocchia, Monica
Publicado 2022

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19

por Gozzetti, Alessandro, Capochiani, Enrico, Bocchia, Monica
Publicado 2020

Daratumumab efficacy in extramedullary orbital myeloma

por Gozzetti, Alessandro, Cerase, Alfonso, Bocchia, Monica
Publicado 2020

Therapeutic Advancements in Multiple Myeloma

por Gozzetti, Alessandro, Candi, Veronica, Papini, Giulia, Bocchia, Monica
Publicado 2014

Editorial: Molecular Mechanisms of Multiple Myeloma

por Gozzetti, Alessandro, Kok, Chung Hoow, Li, Chien-Feng
Publicado 2022

A BRAF-Negative Classic Hairy Cell Leukemia Patient with Long-Lasting Complete Remission after Rituximab and Pentostatin

por Gozzetti, Alessandro, Sammartano, Vincenzo, Bacchiarri, Francesca, Raspadori, Donatella, Bocchia, Monica
Publicado 2020

The Role of Tumor-Associated Macrophages in Hematologic Malignancies

por Cencini, Emanuele, Fabbri, Alberto, Sicuranza, Anna, Gozzetti, Alessandro, Bocchia, Monica
Publicado 2021

Tp53 disruptions: is there a marker of poor prognosis in chronic lymphoproliferative disorders?

por Cencini, Emanuele, Fabbri, Alberto, Raspadori, Donatella, Gozzetti, Alessandro, Bocchia, Monica
Publicado 2021

A case of bone lesion in a patient with relapsed chronic lymphocytic leukemia and review of the literature

por Bacchiarri, Francesca, Gozzetti, Alessandro, Mondanelli, Nicola, Lazzi, Stefano, Bocchia, Monica
Publicado 2022

“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow

por Pacelli, Paola, Raspadori, Donatella, Bestoso, Elena, Gozzetti, Alessandro, Bocchia, Monica
Publicado 2022

Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications

por Cencini, Emanuele, Sicuranza, Anna, Ciofini, Sara, Fabbri, Alberto, Bocchia, Monica, Gozzetti, Alessandro
Publicado 2023

Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET

por Gozzetti, Alessandro, Rossi, Vania, Cerase, Alfonso, Papini, Giulia, Defina, Marzia, Bocchia, Monica
Publicado 2012

Anti CD38 monoclonal antibodies for multiple myeloma treatment

por Gozzetti, Alessandro, Ciofini, Sara, Simoncelli, Martina, Santoni, Adele, Pacelli, Paola, Raspadori, Donatella, Bocchia, Monica
Publicado 2022

Anti-BCMA novel therapies for multiple myeloma

por Sammartano, Vincenzo, Franceschini, Marta, Fredducci, Sara, Caroni, Federico, Ciofini, Sara, Pacelli, Paola, Bocchia, Monica, Gozzetti, Alessandro
Publicado 2023

Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice

por Gozzetti, Alessandro, Raspadori, Donatella, Bacchiarri, Francesca, Sicuranza, Anna, Pacelli, Paola, Ferrigno, Ilaria, Tocci, Dania, Bocchia, Monica
Publicado 2020

Drug resistance and minimal residual disease in multiple myeloma

por Gozzetti, Alessandro, Ciofini, Sara, Sicuranza, Anna, Pacelli, Paola, Raspadori, Donatella, Cencini, Emanuele, Tocci, Dania, Bocchia, Monica
Publicado 2022

Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T‐cell lymphoblastic leukemia

por Zappone, Elisabetta, Cencini, Emanuele, Defina, Marzia, Sicuranza, Anna, Gozzetti, Alessandro, Ciofini, Sara, Raspadori, Donatella, Mecacci, Bianca, Bocchia, Monica
Publicado 2020

Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI

por Santoni, Adele, Simoncelli, Martina, Franceschini, Marta, Ciofini, Sara, Fredducci, Sara, Caroni, Federico, Sammartano, Vincenzo, Bocchia, Monica, Gozzetti, Alessandro
Publicado 2022